Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
SPRINGFIELD NUTRACEUTICALS BELGIUM from Heist-op-den-Berg, company number BE0883345544, closed financial year 2025 with a result of € -29,475 after tax. For that financial year SPRINGFIELD NUTRACEUTICALS BELGIUM recorded a gross margin of € -27,770 and equity of € 19,828. Compared with financial year 2024, the result moved from € 12,041 to € -29,475. The company made a loss. The buffer shrank hard: equity is 60 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 19,828
▼ 60% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -29,475
▼ still € 12,041 profit in 2024
Profit after tax over the fiscal year.
€ 85,263
▲ € 69,439 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 1,228.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 791
▼ 48% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,380
▼ 88% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 63,981
▲ 286% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 14,686 | € 34,463 | € 24,070 | € -27,770 | ▼ € 51,840 |
| Profit after taxes | € 6,216 | € 17,721 | € 12,041 | € -29,475 | ▼ € 41,516 |
| Equity | € 31,541 | € 37,263 | € 49,304 | € 19,828 | ▼ 60% |
| Total debts | € 42,218 | € 25,019 | € 30,227 | € 66,711 | ▲ 121% |
| Cash | € 3,006 | € 18,764 | € 15,824 | € 85,263 | ▲ € 69,439 |
| Retained profit | € 12,941 | € 18,663 | € 30,704 | € 1,228 | ▼ 96% |
| Dividend | € 0 | € 12,000 | € 0 | € 0 | |
| Balance sheet total | € 73,759 | € 62,282 | € 79,531 | € 86,540 | ▲ 9% |
Key figures of SPRINGFIELD NUTRACEUTICALS BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SPRINGFIELD NUTRACEUTICALS BELGIUM?
What happened at SPRINGFIELD NUTRACEUTICALS BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 29,475 (▼ € 41,516 vs 2024). filed late Source: NBB ↗
- New establishment in Heist-op-den-Berg. KBO
- Jelle D'HELFT became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 6,216 profit in 2022 to € 29,475 loss in 2025.
Paid € 17,195 in corporate taxes since 2022.
Best year ever: 2023, with € 17,721 profit.
Paid out € 12,000 in dividends to the owners in total.
A new publication or filing at SPRINGFIELD NUTRACEUTICALS BELGIUM? We notify you, reason included.
Follow SPRINGFIELD NUTRACEUTICALS BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SPRINGFIELD NUTRACEUTICALS BELGIUM are SPRINGFIELD NUTRACEUTICALS BV BO and Jelle D'HELFT.
Directors
According to the 2025 annual accounts
SPRINGFIELD NUTRACEUTICALS BV BO
Director · represented by Linda NATEROP
Jelle D'HELFT
Director
since 2006
Establishments
Establishment units
Physical locations of this company
Lodewijk Liekenswijk 10B
2220 Heist-op-den-Berg
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0883.345.544
- VAT number
- BE 0883.345.544
- Registered office
- Lodewijk Liekenswijk 10B, 2220 Heist-op-den-Berg
- Names & denominations
- SPRINGFIELD NUTRACEUTICALS BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 September 2006
- Peppol
- Not registered
- Activities · NACE
Handelsbemiddeling in de groothandel in voedings- en genotmiddelen
Handelsbemiddeling in voedings- en genotmiddelen
Overige detailhandel in voedingsmiddelen, neg
Overige detailhandel in voedings- en genotmiddelen in gespecialiseerde winkels, n.e.g.
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.